PK and PD Flashcards
Pharmakinetics (PK):
“What the body does to the drug”
ADME
absorption
distribution
metabolism
excretion
Goal: Control the amount of drug exposure
PK is what the body does to a drug during the processes of drug ADME.
(PD) Pharmacodynamics:
“What the drug does to the body”, so there is this-
Relationship between drug concentration at the site of activity (receptor) and effects (therapeutic and toxic).
Goal: To control drug response
PD is, what the DRUG does to the human body.
When a drug is given Intravascularly (e.g. intravenously (IV) or intraarterially), _______________ is NOT required because the drug enters directly into the blood stream.
absorption
If a drug is administered Extravascularly, drug absorption occurs as the drug moves from the site of administration to the bloodstream.
oral, sublingual, buccal, IM, SC, transdermal, inhaled, topical, ocular, intraocular, intrathecal and rectal products.
Most oral drug absorption occurs in the ______
small intestine, because of the large surface area and permeable membrane.
ABSORPTION:
Oral drug is taken and gets dissolved in stomach.
Then drug goes into the Small intestine [where MOST Drug absorption occurs]
After drug is absorbed, drug ENTERS PORTAL VEIN and travels to the Liver.
At the Liver, the drug is METABOLIZED before it reaches systemic circulation; this is also called 1st PASS METABOLISM.
“or”
the drug can be excreted back into the small intestine transported through bile where it can be reabsorbed. This is also called enterohepatic recycling.
gut = GI system, stomach, intestines and colon
Systemic Absorption can occur via:
1)
2)
1) Active transport
- utilizes transporter proteins
- drugs are moved across the gut wall via transport proteins that are normally used to absorb nutrients from food
- Requires Energy
2) Passive transport
- concentration gradient [area of HIGH concentration (e.g. gut lumen) to an area of LOW concentration (e.g. blood)]
- No energy needed
Local vs Systemic Effects:
Intravascular administration [NO ABSORPTION PHASE]
- Intravenous
- Intra-arterial
Extravascular administration [ABSORPTION OCCURS]
- oral (SYSTEMIC activity)
- sublingual (SYSTEMIC activity)
- buccal (SYSTEMIC activity)
- IM (SYSTEMIC activity)
- SC (SYSTEMIC activity)
- dermal (LOCAL activity)
-
- pulmonary (LOCAL activity)
- Topical ocular (LOCAL activity)
- intraocular (LOCAL activity)
ABSORPTION is dependent on a process called ___________
DISSOLUTION
Dosage form Dissolution and Drug solubility:
Dissolution: _______
Dissolution rate (is described by the Noyes-Whitney equation) can be increased by:
___________ & __________
Solubility is increased with _________
Dissolution
- process of drug dissolving in the GI tract and release active drug
Dissolution rate (Noyes-Whitney equation) can be increased by:
- reducing particle size (micronized formulations)
- increasing surface area
Ways to limit drug degradation for drugs destroyed by the gut
- Enteric coating [e.g. Dulcolax, Entocort-budesonide]
Solubility is increased with hydrophilic drugs (water-loving)
“Poorly soluble drugs are generally lipophilic, or fat-loving”
Freely soluble drugs are generally hydrophilic, or water loving.
In General:
- IV, SL, ODT, IR tablet, ER tablet.
- percentage of drug (0-100%) absorbed from the extravascular (usually oral) administration relative to intravascular administration (IV)
- High > 70% = drug with good absorption
- (e.g.
- Low < 10% = drug with poor absorption
-(e.g. bisphosphonates, like ibandronate have low bioavailability)
Some drugs have 100% oral bioavailability:
- Levofloxacin, Linezolid
- Allows for therapeutic interchange between IV and oral formulations
Some drugs
Bioavailability (F):
- the extent of drug absorption into the systemic circulation.
- reflects the percentage of drug absorbed from the extravascular compared to the intravascular administration.
Bioavailability (F):
Is affected by:
- Solubility
- Dissolution (when a drug dosage form dissolves and releases active ingredient)
- Route of administration
- other factors (drug particle size, drug charge, Fat-loving, Water-loving)
Calculating Bioavailability:
- can be calculated using the (AUC) area under the plasma concentration time curve, or AUC.
- the (AUC) area under the curve represents the TOTAL systemic exposure to the drug following administration.
- Equation:
F(%) = 100 x (AUC extravascular / AUC intravascular) x (Dose intravenous / Dose extravascular)
Different Dosage Forms of the same drug (e.g. tablet vs solution) may have different bioavailability’s.
What formula can be used to calculate an equivalent dose of a drug when the dosage form is changed?
Dose of NEW DOSAGE FORM =
(Amount of drug absorbed from current dosage form) / (Bioavailability (F) of NEW DOSAGE FORM)
-
-
Antibodies can be used to target distribution of therapeutics to specific tissues and organs.
- process by which drug molecules move from systemic circulation to tissues and organs.
_____________________________________________________________________________
- lipophilicity (affinity for lipids)
- molecular weight
- ionization status (charged or uncharged)
- protein binding
Factors that favor passage across membranes and greater drug distribution to the tissues include:
-
-
- HIGH Lipophilicity
[drug will favor going into tissues rather than staying in the blood] - Low molecular weight
[big bulky compounds don’t cross membranes very well, so a LOW MOLECULAR WEIGHT will favor drug being able to distribute into tissue rather than staying in the blood] - Low protein binding
[Many drugs are bound to proteins, if a drug has LOW PROTEIN BINDING that means there is more of the free drug in the blood, meaning there is more drug available to distribute to the tissues.] {versus a drug that is very highly protein bound, it is going to stay on the protein, which is in the bloodstream.) - unionized status
[UNCHARGED MOLECULES are those that are able to cross membranes more easily and distribute to tissues, whereas a charged molecule is more likely to stay in the blood]
Albumin-
the primary protein responsible for drug binding